Results 161 to 170 of about 5,416,305 (343)

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

Arthritis Care &Research, Accepted Article.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel   +19 more
wiley   +1 more source

Morphological and phylogenetic analyses reveal two new species of <i>Niesslia</i> (Niessliaceae, Hypocreales) from China. [PDF]

MycoKeys
Tian X, Zhang MY, Hou JG, Wu YJ, Zhang ZY.   +4 more
europepmc   +1 more source

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

Hypertension Research, 2019
S. Umemura, H. Arima, Shuji Arima, K. Asayama, Y. Dohi, Y. Hirooka, T. Horio, S. Hoshide, S. Ikeda, T. Ishimitsu, Masaaki Ito, S. Ito, Y. Iwashima, H. Kai, K. Kamide, Y. Kanno, Naoki Kashihara, Y. Kawano, T. Kikuchi, K. Kitamura, T. Kitazono, K. Kohara, M. Kudo, H. Kumagai, K. Matsumura, Hideo Matsuura, K. Miura, M. Mukoyama, Satoko Nakamura, T. Ohkubo, Y. Ohya, T. Okura, H. Rakugi, S. Saitoh, Hirotaka Shibata, T. Shimosawa, Hiromichi Suzuki, Shori Takahashi, K. Tamura, H. Tomiyama, T. Tsuchihashi, S. Ueda, Y. Uehara, H. Urata, N. Hirawa   +44 more
semanticscholar   +1 more source

Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink, Austin Wheeler, Bryant R. England, Solbritt Rantapää‐Dahlqvist   +3 more
wiley   +1 more source

Referee report. For: Cardiovascular implications of coronavirus disease 2019: a systematic review [version 1; peer review: 2 not approved]

, 2021
Sanjeet Singh Avtaar Singh
openalex   +1 more source

The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

European Heart Journal, 2019
P. Grant, F. Cosentino
semanticscholar   +1 more source

Performance Characteristics of Anti‐Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, Accepted Article.
Background Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti‐collagen II (anti‐Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

Nutrición y Alimentación

Revista Colombiana de Ciencias Pecuarias, 2019
ENICIP 2019
doaj  

Trends in Transgender Care: A Decade of Gender-Affirming Hysterectomies and Ovarian Conservation. [PDF]

O G Open
Radoc JG, Zhao Y, Tucker LY, Huynh A, Ritterman Weintraub ML, Zaritsky E.   +5 more
europepmc   +1 more source

Evaluating Recruitment of American Eel, Anguilla rostrata, in the Potomac River (Spring 2019)

, 2019
Troy D. Tuckey, Mary C. Fabrizio
openalex   +2 more sources